Kelly Rauber
Personalreferent bei VERA THERAPEUTICS, INC.
Aktive Positionen von Kelly Rauber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERA THERAPEUTICS, INC. | Personalreferent | 01.10.2022 | - |
Karriereverlauf von Kelly Rauber
Ehemalige bekannte Positionen von Kelly Rauber
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DERMIRA, INC. | Personalreferent | - | - |
ORCHARD THERAPEUTICS PLC | Personalreferent | - | - |
ORIC PHARMACEUTICALS, INC. | Personalreferent | - | - |
Ausbildung von Kelly Rauber
Santa Clara University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 2 |
Operativ
Human Resources Officer | 4 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ORIC PHARMACEUTICALS, INC. | Health Technology |
VERA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Kelly Rauber
- Erfahrung